PER
Click for more information
1.22% 8.1¢ percheron therapeutics limited

Regarding endpoints, and this is probably why there isn’t...

  1. Ginger_steps_
    1,998 Posts.
    lightbulb Created with Sketch. 748
    clock Created with Sketch.
    02/08/21
    16:01
    Post #: 54967526
    Regarding endpoints, and this is probably why there isn’t significant institutional interest - the P2 trial only had 9 participants didn’t it? I ask genuinely because I might have bad intel. If that is correct, then there is a material risk of those results not being replicated over say 100/200 participants. Also adding in combination therapies etc further adds to the risk. We are not over the finish line yet, but definitely showing real promise.
    ANP Price at posting: 21.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 8  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢ 		Change
-0.001(1.22%) 		Mkt cap ! $73.02M
Open High Low Value Volume
8.0¢ 8.3¢ 8.0¢ $52.59K 651.3K

Buyers (Bids)

No. Vol. Price($)
1 56645 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 109832 2
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.